Astec Lifesciences Limited(IN:ASTEC)
₹558.25+4.15 (+0.75%)
IN:ASTEC
Astec Lifesciences Limited earnings date
₹558.25
At close:+4.15 (+0.75%)
Want to see IN:ASTEC full AI Analyst Report?
Astec Lifesciences Limited (ASTEC) Q2 2022 Earnings Report
1 Followers
IN:ASTEC Q2 2022 EPS Results
- Actual EPS
- INR 4.57
- Consensus EPS
- INR 510.13
- Beat/Miss
- Missed by -INR 505.57
- One Year Ago EPS
- INR 9.03
IN:ASTEC Q2 2022 Revenue Results
- Actual Revenue
- INR 1.03B
- Expected Revenue
- INR 112.57B
- Beat/Miss
- Missed by -INR 111.54B
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 10/27/2021
- Time
- Before Open
- Conference Call
- Wednesday, October 27, 2021
IN:ASTEC Upcoming Earnings
Astec Lifesciences Limited's next earnings date is estimated for January 27, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
IN:ASTEC Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 27, 2027 | 2027 (Q3) | ―- | -6.95 | ― | ― |
| Oct 26, 2026 | 2027 (Q2) | -15.90-15.90 | -11 | -44.55% (-4.90) | |
| Jul 31, 2026 | 2027 (Q1) | -8.85-8.40 | -16.9 | 50.30% (+8.50) | |
| Apr 27, 2026 | 2026 (Q4) | 0.50-3.75 | -8.2 | 54.27% (+4.45) | |
| Jan 30, 2026 | 2026 (Q3) | -6.30-6.95 | -20.45 | 66.02% (+13.50) | |
| Oct 29, 2025 | 2026 (Q2) | -12.45-11.00 | -19.56 | 43.75% (+8.56) | |
| Jul 28, 2025 | 2026 (Q1) | -9.70-16.90 | -20.15 | 16.14% (+3.25) | |
| Apr 23, 2025 | 2025 (Q4) | -13.50-8.20 | -0.5 | -1553.23% (-7.70) | |
| Jan 27, 2025 | 2025 (Q3) | -16.98-20.45 | -12.31 | -66.13% (-8.14) | |
| Oct 25, 2024 | 2025 (Q2) | -16.68-19.56 | -6.85 | -185.50% (-12.71) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

